Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 722-731 , November 2007

Prospective Evaluation of Beta-Blocker Use at the Time of Hospital Discharge as a Heart Failure Performance Measure: Results From OPTIMIZE-HF

  • Gregg C. Fonarow, MD

      Affiliations

    • Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California
    • Corresponding Author InformationReprint requests: Gregg C. Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Avenue, Room 47-123 CHS, Los Angeles, CA 90095-1679.
    • ,
  • William T. Abraham, MD, FACP, FACC,

      Affiliations

    • Division of Cardiology, The Ohio State University, Columbus, Ohio
    • ,
  • Nancy M. Albert, PhD, RN

      Affiliations

    • George M. and Linda H. Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Wendy Gattis Stough, PHARMD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, North Carolina, and Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, North Carolina
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Barry H. Greenberg, MD

      Affiliations

    • Department of Medicine, UCSD Medical Center, University of California, San Diego, California
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Jie Lena Sun, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas (Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas [current affiliation])
    • ,
  • James B. Young, MD

      Affiliations

    • Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • on behalf of the OPTIMIZE-HF Investigators and Coordinators

Received 22 January 2007 ,Revised 17 May 2007 ,Accepted 20 June 2007.

References 

  1. American Heart Association . Heart disease and stroke statistics—2007 update. Dallas, TX: American Heart Association; 2007;
  2. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235Epub 2005 Sep 13
  3. Adams KF, Lindenfeld J, Arnold JMO, Baker DW, Barnard DH, Baughman KL, et al. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12:e1–e122
  4. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Am Coll Cardiol. 2001;38:2101–2113
  5. Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand SL. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005;45:1147–1156
  6. Bonow RO, Bennett S, Casey DE, Ganiats TG, Hlatky MA, Konstam MA, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 2005;46:1144–1178
  7. Joint Commission on Accreditation of Healthcare Organizations . Specification manual for national implementation of hospital core measures. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 2004;
  8. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148:43–51
  9. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217–2226
  10. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61–70
  11. CIBIS-II Investigators . The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13
  12. MERIT-HF Investigators . Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
  13. Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658
  14. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7–13
  15. Cohn JN. New therapeutic strategies for heart failure: left ventricular remodeling as a target. J Card Fail. 2004;10:S200–S201
  16. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248–254
  17. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 2001;134:550–560
  18. Garg R, Yusuf S Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450–1456
  19. Packer M, Fowler MB, Roecker EB, Coats AJS, Katus HA, Krum H, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study. Circulation. 2002;106:2194–2199
  20. Butler J, Young JB, Abraham WT, Bourge RC, Adams KF, Clare R, et al. Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol. 2006;47:2462–2469
  21. Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol. 2004;43:1534–1541
  22. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002;360:1631–1639
  23. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209–216
  24. Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294:1240–1247

 The OPTIMIZE-HF registry is registered: www.clinicaltrials.gov, study number NCT00344513. The OPTIMIZE-HF registry and this study were funded by GlaxoSmithKline, Philadelphia, Pennsylvania.

PII: S1071-9164(07)00942-6

doi: 10.1016/j.cardfail.2007.06.727

Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 722-731 , November 2007

Article Tools

* Image Usage & Resolution